Industry Wants Continued Dialogue to Keep Price Maintenance Premium in Place: Janssen Japan Chief

Janssen Japan Chief Chris Hourigan The pharmaceutical industry wants to have a continued dialogue with the Japanese government so that the so-called price maintenance premium for on-patent medicines will remain in place to support innovation, Janssen Japan chief Chris Hourigan...read more